MIAMI Trial: Difference between revisions
Jump to navigation
Jump to search
Adeeljamil (talk | contribs) No edit summary |
m Robot: Automated text replacement (-{{SIB}} + & -{{EH}} + & -{{EJ}} + & -{{Editor Help}} + & -{{Editor Join}} +) |
||
| Line 3: | Line 3: | ||
{{CMG}} | {{CMG}} | ||
: '''MIAMI''' <ref name="pmid3933320">{{cite journal |author= |title=Metoprolol in acute myocardial infarction. Patient population. The MIAMI Trial Research Group |journal=Am. J. Cardiol. |volume=56 |issue=14 |pages=10G–14G |year=1985 |month=November |pmid=3933320 |doi= |url=}}</ref> <ref name="pmid3904393">{{cite journal |author= |title=Metoprolol in acute myocardial infarction. Other clinical findings and tolerability. The MIAMI Trial Research Group |journal=Am. J. Cardiol. |volume=56 |issue=14 |pages=39G–46G |year=1985 |month=November |pmid=3904393 |doi= |url=}}</ref> <ref name="pmid3904392">{{cite journal |author= |title=Metoprolol in acute myocardial infarction. Arrhythmias. The MIAMI Trial Research Group |journal=Am. J. Cardiol. |volume=56 |issue=14 |pages=35G–38G |year=1985 |month=November |pmid=3904392 |doi= |url=}}</ref> <ref name="pmid3904391">{{cite journal |author= |title=Metoprolol in acute myocardial infarction. Enzymatic estimation of infarct size. The MIAMI Trial Research Group |journal=Am. J. Cardiol. |volume=56 |issue=14 |pages=27G–29G |year=1985 |month=November |pmid=3904391 |doi= |url=}}</ref> <ref name="pmid3904390">{{cite journal |author= |title=Metoprolol in acute myocardial infarction. Development of myocardial infarction. The MIAMI Trial Research Group |journal=Am. J. Cardiol. |volume=56 |issue=14 |pages=23G–26G |year=1985 |month=November |pmid=3904390 |doi= |url=}}</ref> <ref name="pmid3904389">{{cite journal |author= |title=Metoprolol in acute myocardial infarction. Mortality. The MIAMI Trial Research Group |journal=Am. J. Cardiol. |volume=56 |issue=14 |pages=15G–22G |year=1985 |month=November |pmid=3904389 |doi= |url=}}</ref> <ref name="pmid2865890">{{cite journal |author= |title=Metoprolol in acute myocardial infarction. Narcotic analgesics and other antianginal drugs. The MIAMI Trial Research Group |journal=Am. J. Cardiol. |volume=56 |issue=14 |pages=30G–34G |year=1985 |month=November |pmid=2865890 |doi= |url=}}</ref> <ref name="pmid2865889">{{cite journal |author= |title=Metoprolol in acute myocardial infarction. Patients and methods. The MIAMI Trial Research Group |journal=Am. J. Cardiol. |volume=56 |issue=14 |pages=3G–9G |year=1985 |month=November |pmid=2865889 |doi= |url=}}</ref> | : '''MIAMI''' <ref name="pmid3933320">{{cite journal |author= |title=Metoprolol in acute myocardial infarction. Patient population. The MIAMI Trial Research Group |journal=Am. J. Cardiol. |volume=56 |issue=14 |pages=10G–14G |year=1985 |month=November |pmid=3933320 |doi= |url=}}</ref> <ref name="pmid3904393">{{cite journal |author= |title=Metoprolol in acute myocardial infarction. Other clinical findings and tolerability. The MIAMI Trial Research Group |journal=Am. J. Cardiol. |volume=56 |issue=14 |pages=39G–46G |year=1985 |month=November |pmid=3904393 |doi= |url=}}</ref> <ref name="pmid3904392">{{cite journal |author= |title=Metoprolol in acute myocardial infarction. Arrhythmias. The MIAMI Trial Research Group |journal=Am. J. Cardiol. |volume=56 |issue=14 |pages=35G–38G |year=1985 |month=November |pmid=3904392 |doi= |url=}}</ref> <ref name="pmid3904391">{{cite journal |author= |title=Metoprolol in acute myocardial infarction. Enzymatic estimation of infarct size. The MIAMI Trial Research Group |journal=Am. J. Cardiol. |volume=56 |issue=14 |pages=27G–29G |year=1985 |month=November |pmid=3904391 |doi= |url=}}</ref> <ref name="pmid3904390">{{cite journal |author= |title=Metoprolol in acute myocardial infarction. Development of myocardial infarction. The MIAMI Trial Research Group |journal=Am. J. Cardiol. |volume=56 |issue=14 |pages=23G–26G |year=1985 |month=November |pmid=3904390 |doi= |url=}}</ref> <ref name="pmid3904389">{{cite journal |author= |title=Metoprolol in acute myocardial infarction. Mortality. The MIAMI Trial Research Group |journal=Am. J. Cardiol. |volume=56 |issue=14 |pages=15G–22G |year=1985 |month=November |pmid=3904389 |doi= |url=}}</ref> <ref name="pmid2865890">{{cite journal |author= |title=Metoprolol in acute myocardial infarction. Narcotic analgesics and other antianginal drugs. The MIAMI Trial Research Group |journal=Am. J. Cardiol. |volume=56 |issue=14 |pages=30G–34G |year=1985 |month=November |pmid=2865890 |doi= |url=}}</ref> <ref name="pmid2865889">{{cite journal |author= |title=Metoprolol in acute myocardial infarction. Patients and methods. The MIAMI Trial Research Group |journal=Am. J. Cardiol. |volume=56 |issue=14 |pages=3G–9G |year=1985 |month=November |pmid=2865889 |doi= |url=}}</ref> | ||
| Line 13: | Line 13: | ||
[[Category:Randomized trials]] | [[Category:Randomized trials]] | ||
[[Category:Cardiology]] | [[Category:Cardiology]] | ||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} | ||
Latest revision as of 17:06, 9 August 2012
|
WikiDoc Resources for MIAMI Trial |
|
Articles |
|---|
|
Most recent articles on MIAMI Trial Most cited articles on MIAMI Trial |
|
Media |
|
Powerpoint slides on MIAMI Trial |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on MIAMI Trial at Clinical Trials.gov Clinical Trials on MIAMI Trial at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on MIAMI Trial
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on MIAMI Trial Discussion groups on MIAMI Trial Patient Handouts on MIAMI Trial Directions to Hospitals Treating MIAMI Trial Risk calculators and risk factors for MIAMI Trial
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for MIAMI Trial |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
- MIAMI [1] [2] [3] [4] [5] [6] [7] [8]
- In the Metoprolol In Acute Myocardial Infarction (MIAMI) trial, STEMI patients were randomized to receive either metoprolol (up to 15 mg IV in 3 divided doses followed by 50 mg orally every six hours for 48 hours and then 100 mg twice per day thereafter) or placebo (n=5,700 patients). There was a favorable trend in mortality at 15 days (4.3% vs 4.9%) which was sustained over time. The benefits of metroprolol were greater in high risk patients. [6]
References
- ↑ "Metoprolol in acute myocardial infarction. Patient population. The MIAMI Trial Research Group". Am. J. Cardiol. 56 (14): 10G–14G. 1985. PMID 3933320. Unknown parameter
|month=ignored (help) - ↑ "Metoprolol in acute myocardial infarction. Other clinical findings and tolerability. The MIAMI Trial Research Group". Am. J. Cardiol. 56 (14): 39G–46G. 1985. PMID 3904393. Unknown parameter
|month=ignored (help) - ↑ "Metoprolol in acute myocardial infarction. Arrhythmias. The MIAMI Trial Research Group". Am. J. Cardiol. 56 (14): 35G–38G. 1985. PMID 3904392. Unknown parameter
|month=ignored (help) - ↑ "Metoprolol in acute myocardial infarction. Enzymatic estimation of infarct size. The MIAMI Trial Research Group". Am. J. Cardiol. 56 (14): 27G–29G. 1985. PMID 3904391. Unknown parameter
|month=ignored (help) - ↑ "Metoprolol in acute myocardial infarction. Development of myocardial infarction. The MIAMI Trial Research Group". Am. J. Cardiol. 56 (14): 23G–26G. 1985. PMID 3904390. Unknown parameter
|month=ignored (help) - ↑ 6.0 6.1 "Metoprolol in acute myocardial infarction. Mortality. The MIAMI Trial Research Group". Am. J. Cardiol. 56 (14): 15G–22G. 1985. PMID 3904389. Unknown parameter
|month=ignored (help) - ↑ "Metoprolol in acute myocardial infarction. Narcotic analgesics and other antianginal drugs. The MIAMI Trial Research Group". Am. J. Cardiol. 56 (14): 30G–34G. 1985. PMID 2865890. Unknown parameter
|month=ignored (help) - ↑ "Metoprolol in acute myocardial infarction. Patients and methods. The MIAMI Trial Research Group". Am. J. Cardiol. 56 (14): 3G–9G. 1985. PMID 2865889. Unknown parameter
|month=ignored (help)